The World of Health & Medicine News

Amazon Pharmacy to launch electronic kiosks for prescriptions at One Medical locations

Amazon Pharmacy to launch electronic kiosks for prescriptions at One Medical locations

Amazon said on Wednesday its pharmacy business in December will begin filling some prescriptions for common medications at electronic kiosks in its One Medical primary care locations, which the company says will reduce barriers to access and limit shipping costs.

Amazon plans to start the offer with One Medical patients in Los Angeles for drugs including antibiotics, asthma inhalers and treatments for high blood pressure, the company said.

The kiosks will be the first in-person pick-up service offered by Amazon Pharmacy, which has been providing prescription services primarily by delivery, said Hannah McClellan Richards, a vice president at Amazon Pharmacy.

One Medical offers a membership structure that allows patients to access primary and urgent care at a subscription fee of $199 annually. Patients without a membership are still able to book an appointment and would be able to use the kiosk, the company said.

Richards said in an interview that the company plans to expand the kiosk model outside of California in 2026 and is in talks with external health systems to introduce the machines through partnerships.

Amazon does not plan to offer medicines that must be refrigerated, such as GLP-1 weight-loss drugs, or more tightly regulated prescriptions like controlled pain medicines through the kiosk.

Inventory for each kiosk will be tailored to the provider, and patients would be able to consult a company pharmacist virtually, Amazon said in a press release.

Amazon.com, the $2.34 trillion e-commerce company, launched pharmaceutical delivery in 2018 through its acquisition of PillPack. In 2023, the company purchased One Medical, a national primary care provider.

Analysts this year have flagged shipping and logistical costs as a potential squeeze on Amazon’s profits.

Chief Financial Officer Brian Olsavsky, in a second-quarter earnings call, said the company planned to make strategic decisions on product placement in an effort to shorten delivery routes and improve availability. “We’re committed to initiatives that further improve our cost structure,” he said at the time.

Richards acknowledged that the most expensive part of the e-commerce supply chain is shipping.

“If you put inventory closer to customers,” she said, “your shipping costs go way down and your demand goes way up.”

spot_img

Explore more

spot_img

Bavarian Nordic signs EU smallpox and mpox vaccine contract for up...

Bavarian Nordic signs EU smallpox and mpox vaccine contract for up to 8 million doses Bavarian Nordic announced on Friday a new contract with the...

WHO says mpox now detected in more countries, with 17 deaths...

WHO says mpox now detected in more countries, with 17 deaths in Africa over six weeks The World Health Organization (WHO) said on Friday that...

Metsera the US obesity biotech at centre of Novo, Pfizer bidding...

Metsera the US obesity biotech at centre of Novo, Pfizer bidding war Metsera has become the obesity drug market's hottest ticket. The New York-based biotech is...

Eli Lilly says weight-loss pill a candidate for speedy approval under...

Eli Lilly says weight-loss pill a candidate for speedy approval under new US programme Eli Lilly said its experimental weight-loss pill met most criteria for...

BridgeBio surges as muscle disorder drug scores ‘best case’ trial win

BridgeBio surges as muscle disorder drug scores 'best case' trial win BridgeBio Pharma (BBIO.O), opens new tab said on Monday its experimental drug for a rare muscle...

US FDA warns four firms over unapproved fluoride drugs for children

US FDA warns four firms over unapproved fluoride drugs for children The U.S. Food and Drug Administration said on Friday it warned four companies that...

Inhibrx shares surge after bone cancer drug slows disease progression in...

Inhibrx shares surge after bone cancer drug slows disease progression in trial Inhibrx Biosciences said on Thursday its experimental drug helped slow the progression of...

Investors managing $11.5 trillion urge food companies to diversify away from...

Investors managing $11.5 trillion urge food companies to diversify away from animal proteins  Investors managing $11.5 trillion in assets are calling on major food companies...